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weighted fast spin-echo (3000/80) (T2WI), T2*_T2-weighted 
gradient echo (4000/80) (T2*2D), T2*_3-dimensional T2-
weighted gradient echo [TR/TE1/deltaTE](37/14/7.3) 
(T2*3D), and contrast-enhanced T1-weighted spin-echo 
(607/12) (CE-T1WI) in all cases. Contrast-enhanced T1-
weighted MRI was performed with gadopentetate 
dimeglumine. The quality comparison of the five sequences 
(T1WI, T2WI, T2*2D, T2*3D and CE-T1WI) was conducted by a 
single radiation oncologist and two radiation technologists. 
These observers subjectively scored all of the images based 
on the five following evaluation items: the definition of 
outline of the prostate; apex vs. soft tissue; base vs. bladder; 
base vs. seminal vesicle; and gold fiducial marker detection. 
A score from 1 to 3 (1 [poor], 2 [moderate], 3 [good]) was 
assigned to each of the items accordingly. Higher score was 
regarded as denoting better visualization. We compared the 
mean scores for each item.  
 
Results: 
 
 
 
Our data are shown in the Table. T2WI was significantly 
superior to the other sequences in terms of the definition of 
the prostate. T2*3D was significantly superior to the other 
sequences in terms of the definition of the fiducial marker. 
 
Conclusion: The most important purpose of the study was to 
accurately identify the marker. T2*3D was the best sequence 
for achieving this objective. The superiority of T2*3D in 
defining the marker meant that although T2W1 provided the 
highest level of precision in the outline of the prostate, 
T2*3D provided a better balance between the contouring of 
the prostate and defining the marker. 
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Purpose or Objective: As intensity modulated radiation 
therapy (IMRT) is becoming a standard option for cervical 
cancer radiation therapy (RT), one of the major uncertainty 
components is the definition of the clinical target volume 
(CTV). Despite several guidelines, wide discrepancy can still 
exist. The aim of this study is to determine inter-observer 
variability in delineating CTV for definitive and postoperative 
RT for cervical cancer.  
 
Material and Methods: Eight radiation oncologists from 
different centers whose subspecialty are gynecologic cancer 
contoured CTV on the planning computed tomography (CT) 
scan of two patients, each of definitive and postoperative RT 
case (Fig. 1).  
 
 
 
For volumetric analysis, we compared delineated volumes in 
terms of the individual/median volume ratio, generalized 
conformity index (CIgen). For spatial difference information, 
center of mass (COM) was used. IMRT plan was made based 
on one of the collected CTVs, and dose coverage was 
compared. 
 
Results: The CTV volume for definitive case was 213-918 ml, 
with individual/median volume ratio of 0.51-1.41. The CIgen 
was 0.53. The mean values of the three-dimensional 
distances of the average COM to each COM were 7.8 mm. The 
largest difference was seen in superior-inferior direction, 
depending on common iliac lymph node region coverage and 
the length of inclusion of vagina. On dose coverage analysis, 
95% of prescription dose covered 80.3% (range, 62.2 – 96.0%) 
of planning target volumes (PTV) generated by 8 physicians. 
Parametrial and paravaginal areas were most frequently 
underdosed. The CTV volume for postoperative RT case was 
266-562 ml, with individual/median volume ratio of 0.65-
1.38. The CIgen was 0.563. The mean values of the three-
dimensional distances of the average COM to each COM were 
5.3 mm in postoperative case. Ninety-five percent of 
prescription dose covered 80.9% (range, 66.4 – 94.8%) of 
planning target volumes (PTV) from 8 hospitals. Presacral, 
tumor bed and paravaginal areas were most frequently 
underdosed. 
 
Conclusion: A large inter-physician variability in CTV 
delineation concerning the magnitude and relative location of 
volumes was observed. Continuing education of proposed 
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guidelines on CTV definition and knowledge of commonly 
missed/disconcordant CTV areas cannot be overemphasized 
to avoid such difference. 
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Purpose or Objective: For Toshiba Aquilion LB CT scanners, 
the reconstruction quality of 4DCTs is strongly dependent on 
the accuracy of cycle based online trigger pulses. Two 
consecutive triggers are used to define a breathing cycle 
which is divided into respiratory phases of equal duration. As 
a consequence, any deviation in the length of the inspiration 
or expiration period in relation to the whole breathing cycle 
will result in image artifacts and a higher probability of 
misinterpretations. The aim of this work is to improve 4DCT 
quality by using amplitude based triggers for each individual 
breathing cycle. 
 
Material and Methods: The trigger signals for the 4DCT 
reconstruction are originally provided by the Sentinel™ 
optical surface scanner (C-RAD AB, Sweden) using a threshold 
method in order to generate online trigger pulses. These 
always have to occur before the actual maximum of the 
curve and are used to reconstruct the 4DCT phases based on 
an equally divided breathing cycle (0% - 90% in 10% steps) for 
phase-based reconstruction. A second 4DCT is reconstructed 
using the true inhalation peak triggers created by an offline 
tool, also with phases of equal time for each cycle. 
Furthermore, a single trigger for each breathing phase is sent 
to the CT for a third reconstruction of all motion states based 
on the amplitude (e.g. 10%, 20%, etc.) of the breathing curve 
in relation to the maximum and minimum of one cycle. The 
absolute volume of a tumor inside of a moving chest 
phantom, which serves as a direct measure for reconstruction 
quality, has been determined for each motion state of the 
reconstructed 4DCT for 10 different curves (2 sinusoidal, 8 
patient breathing curves),  
 
Results: Reconstructing the 4DCT solely according to the 
online trigger pulses proposed by Sentinel™can lead to a 
mean deviation in the volume of the tumor of up to 2,98% ± 
4,65% compared to the CT reconstruction of the same tumor 
without any movement. When selecting the optimal trigger 
point at maximum inhalation offline and dividing the 
breathing curve into phases of equal duration, the error in 
volume is reduced to 0,19% ± 2,84%. Generating an amplitude 
based set of trigger pulses for each individual breathing 
cycle, the error in volume has been observed with 0,25% ± 
0,29%. 
 
Conclusion: Although the method of reconstructing 4DCTs 
using the amplitude-based information for each breathing 
cycle provides the best representation of the tumor volume, 
it appears to be quite impractically as every trigger file for 
each phase has to be sent into the CT for a single 
reconstruction of this motion state. This will be hard to 
accomplish in a clinical workflow and is prone to errors. A 
reconstruction of the 4DCTs based on equally divided 
respiration phases over time with the trigger points set to the 
true maximum of the breathing curve serves as a valid 
compromise, with minimal extra workload clinically and 
improved 4DCT image quality. 
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Purpose or Objective: The highly localized dose distribution 
in proton therapy (PT) makes this treatment modality 
sensitive to organ motion and deformations. E.g. in proton 
pencil beam scanning interplay effects may be significant, 
resulting in dose degradations. Due to the complexity of PT 
dose delivery, investigations of the consequences of motion 
and of motion mitigation strategies may benefit from the use 
of 3D dosimetry. A new family of silicone-based 3D 
dosimeters is currently being developed. These dosimeters 
can be moulded into anthropomorphic shapes and can be 
deformed during beam delivery, which allows for simulation 
of organ motion and deformation. 
Treatment planning with protons is based on CT scans of the 
patient anatomy and a conversion of the HU for the tissue to 
a stopping power ratio (SPR) relative to water. To ensure 
that the same procedure can be performed for the dosimeter 
it must be verified that its SPR is estimated correctly from its 
HU. The aim of this study was therefore to investigate if the 
use of Dual Energy (DE) CT and dedicated DE calibrations can 
improve the calculation of the SPR for the dosimeter 
compared to use of Single Energy (SE) CT together with the 
stoichiometric calibration method. 
 
Material and Methods: A thin slab of the dosimeter material 
was placed in a water tank and irradiated with a 60 MeV 
proton beam. The range of the protons was measured with 
and without the dosimeter intersecting the beam to 
determine the range difference. The SPR of the dosimeter 
was calculated from its thickness and the range difference. 
The dosimeter was subsequently CT scanned with a Dual 
Source CT scanner (Siemens Somaton Definition Flash). First a 
CT scan was obtained in SE mode with a tube voltage of 120 
kVp, and this scan was used in the stoichiometric calibration. 
Next a set of CT scans was obtained in DE mode with a tube 
voltage pair of 80/140Sn kVp (Sn: 0.4 mm extra tin 
filtration); this CT image set was used for SPR calculation 
with two published DE calibrations. The CTDIvol of the two 
scanning modes was set to be the same (~20 mGy). 
 
Results: From the range measurements, the SPR of the 
dosimeter was calculated to be SPRmeas = 0.97. The two DE 
calibration methods both gave an estimate of SPRest = 1.01, 
whereas the SE stoichiometric calibration estimate was 
SPRest = 1.10. The measured SPR did not fall on the 
stoichiometric calibration curve of the reference tissues 
(Figure; the high content of silicon makes the dosimeter not 
tissue equivalent). The dosimeter was found to have a HU 
corresponding to bone (CT number = 135 HU) but a SPR 
corresponding to fat. 
 
